{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T09:43:53Z","timestamp":1793699033416,"version":"4.5.1"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,6]]},"abstract":"<jats:sec>\n            <jats:title>Background.<\/jats:title>\n            <jats:p>Organs from Public Health Service criteria (PHSC) donors, previously referred to as PHS infectious-risk donors, have historically been recovered but not used, traditionally referred to as \u201cdiscard,\u201d at higher rates despite negligible risk to recipients. On March 1, 2021, the definition of PHSC donors narrowed to include only the subset of donors deemed to have meaningfully elevated risk in the current era of improved infectious disease testing.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods.<\/jats:title>\n            <jats:p>Using Scientific Registry of Transplant Recipients data from May 1, 2019, to December 31, 2022, we compared rates of PHSC classification and nonutilization of PHSC organs before versus after the March 1, 2021, policy change among recovered decedents using the \u03c7<jats:sup>2<\/jats:sup> tests. We performed an adjusted interrupted time series analysis to examine kidney and liver recovery\/nonuse (traditionally termed \u201cdiscard\u201d) and kidney, liver, lung, and heart nonutilization (nonrecovery or recovery\/nonuse) prepolicy versus postpolicy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results.<\/jats:title>\n            <jats:p>PHSC classification dropped sharply from 24.5% prepolicy to 15.4% postpolicy (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u20050.001). Before the policy change, PHSC kidney recovery\/nonuse, liver nonuse, lung nonuse, and heart nonuse were comparable to non-PHSC estimates (adjusted odds ratio: kidney\u2005=\u2005<jats:sub>0.98<\/jats:sub>1.06<jats:sub>1.14<\/jats:sub>, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u20050.14; liver\u2005=\u2005<jats:sub>0.85<\/jats:sub>0.92<jats:sub>1.01<\/jats:sub>, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u20050.07; lung\u2005=\u2005<jats:sub>0.91<\/jats:sub>0.99<jats:sub>1.08<\/jats:sub>, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u20050.83; heart\u2005=\u2005<jats:sub>0.89<\/jats:sub>0.97<jats:sub>1.05<\/jats:sub>, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u20050.47); following the policy change, PHSC kidney recovery\/nonuse, liver nonuse, lung nonuse, and heart nonuse were lower than non-PHSC estimates (adjusted odds ratio: kidney\u2005=\u2005<jats:sub>0.77<\/jats:sub>0.84<jats:sub>0.91<\/jats:sub>, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u20050.001; liver\u2005=\u2005<jats:sub>0.77<\/jats:sub>0.84<jats:sub>0.92<\/jats:sub>, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u20050.001; lung\u2005=\u2005<jats:sub>0.74<\/jats:sub>0.81<jats:sub>0.90<\/jats:sub>, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u20050.001; heart\u2005=\u2005<jats:sub>0.61<\/jats:sub>0.67<jats:sub>0.73<\/jats:sub>, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u20050.001).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions.<\/jats:title>\n            <jats:p>Even though PHSC donors under the new definition are a narrower and theoretically riskier subpopulation than under the previous classification, PHSC status appears to be associated with a reduced risk of kidney and liver recovery\/nonuse and nonutilization of all organs. Although historically PHSC organs have been underused, our findings demonstrate a notable shift toward increased PHSC organ utilization.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/tp.0000000000004929","type":"journal-article","created":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T05:02:09Z","timestamp":1708059729000},"page":"1440-1447","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Organ Nonutilization Following Revision to the Public Health Service Donor Risk Criteria for HIV, HCV, or HBV Transmission"],"prefix":"10.1097","volume":"108","author":[{"given":"Suhani S.","family":"Patel","sequence":"first","affiliation":[{"name":"Department of Surgery, Transplant Institute, NYU Langone Health, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline I.","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Surgery, Transplant Institute, NYU Langone Health, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren E.","family":"Stewart","sequence":"additional","affiliation":[{"name":"Department of Surgery, Transplant Institute, NYU Langone Health, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorry L.","family":"Segev","sequence":"additional","affiliation":[{"name":"Department of Surgery, Transplant Institute, NYU Langone Health, New York, New York."},{"name":"Scientific Registry of Transplant Recipients, Minneapolis, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan B.","family":"Massie","sequence":"additional","affiliation":[{"name":"Department of Surgery, Transplant Institute, NYU Langone Health, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,2,16]]},"reference":[{"key":"R1-20250604","doi-asserted-by":"crossref","first-page":"61","DOI":"10.15585\/mmwr.mm6803a2","article-title":"Characteristics of deceased solid organ donors and screening results for hepatitis B, C, and human immunodeficiency viruses\u2014United States, 2010\u20132017.","volume":"68","author":"Abara","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R2-20250604","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1111\/ajt.15393","article-title":"Quantifying the risk of undetected HIV, hepatitis B virus, or hepatitis C virus infection in public health service increased risk donors.","volume":"19","author":"Jones","year":"2019","journal-title":"Am J Transplant"},{"key":"R3-20250604","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/MOT.0b013e3283449dd3","article-title":"High infectious risk donors: what are the risks and when are they too high?","volume":"16","author":"Kucirka","year":"2011","journal-title":"Curr Opin Organ Transplant"},{"key":"R4-20250604","first-page":"1","article-title":"Assessing solid organ donors and monitoring transplant recipients for human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection\u2014US Public Health Service Guideline, 2020.","volume":"69","author":"Jones","year":"2020","journal-title":"MMWR"},{"key":"R6-20250604","doi-asserted-by":"crossref","first-page":"702","DOI":"10.7326\/M17-2451","article-title":"The drug overdose epidemic and deceased-donor transplantation in the United States.","volume":"168","author":"Durand","year":"2018","journal-title":"Ann Intern Med"},{"key":"R7-20250604","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/j.1600-6143.2009.02931.x","article-title":"Centers for disease control \u2018high-risk\u2019 donors and kidney utilization.","volume":"10","author":"Duan","year":"2010","journal-title":"Am J Transplant"},{"key":"R8-20250604","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1111\/ajt.15388","article-title":"Impact of US Public Health Service increased risk deceased donor designation on organ utilization.","volume":"19","author":"Sapiano","year":"2019","journal-title":"Am J Transplant"},{"key":"R9-20250604","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1097\/TP.0000000000001716","article-title":"Deceased organ donors and PHS risk identification.","volume":"101","author":"Pruett","year":"2017","journal-title":"Transplantation"},{"key":"R10-20250604","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/9658904","article-title":"Utilization of Public Health Service increased risk donors yields equivalent outcomes in liver transplantation.","volume":"2016","author":"Fleetwood","year":"2016","journal-title":"J Transplant"},{"key":"R11-20250604","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/lt.25009","article-title":"What are the outcomes of declining a public health service increased risk liver donor for patients on the liver transplant waiting list?","volume":"24","author":"Croome","year":"2018","journal-title":"Liver Transplant"},{"key":"R12-20250604","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1097\/TP.0000000000001673","article-title":"The \u201cPHS increased risk\u201d label is associated with nonutilization of hundreds of organs per year.","volume":"101","author":"Volk","year":"2017","journal-title":"Transplantation"},{"key":"R13-20250604","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1111\/ajt.12206","article-title":"Identifying appropriate recipients for CDC infectious risk donor kidneys.","volume":"13","author":"Chow","year":"2013","journal-title":"Am J Transplant"},{"key":"R14-20250604","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/ajt.14577","article-title":"Turn down for what? Patient outcomes associated with declining increased infectious risk kidneys.","volume":"18","author":"Bowring","year":"2018","journal-title":"Am J Transplant"},{"key":"R17-20250604","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1093\/cid\/ciy585","article-title":"Hepatitis C guidance 2018 update: AASLD-IDSA recommendations for testing, managing, and treating hepatitis C virus infection.","volume":"67","author":"Chung","year":"2018","journal-title":"Clin Infect Dis"},{"key":"R18-20250604","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/hep.29800","article-title":"Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance.","volume":"67","author":"Terrault","year":"2018","journal-title":"Hepatology"},{"key":"R19-20250604","doi-asserted-by":"crossref","first-page":"e13879","DOI":"10.1111\/ctr.13879","article-title":"Increased risk donor criteria: the time for change is now.","volume":"34","author":"Wakam","year":"2020","journal-title":"Clin Transplant"},{"key":"R20-20250604","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1097\/TP.0000000000001715","article-title":"Potential impact of risk and loss aversion on the process of accepting kidneys for transplantation.","volume":"101","author":"Heilman","year":"2017","journal-title":"Transplantation"},{"key":"R21-20250604","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/MOT.0000000000000954","article-title":"Misplaced emphasis, misunderstood risk: a cultural history of Public Health Service infectious disease guidelines.","volume":"27","author":"Hendele","year":"2022","journal-title":"Curr Opin Organ Transplant"},{"key":"R22-20250604","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1111\/ajt.12777","article-title":"Big data in organ transplantation: registries and administrative claims.","volume":"14","author":"Massie","year":"2014","journal-title":"Am J Transplant"},{"key":"R23-20250604","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/biostatistics\/kxn014","article-title":"Effective communication of standard errors and confidence intervals.","volume":"10","author":"Louis","year":"2008","journal-title":"Biostatistics"},{"key":"R24-20250604","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/ajt.13976","article-title":"Changes in utilization and discard of hepatitis C\u2013infected donor livers in the recent era.","volume":"17","author":"Bowring","year":"2017","journal-title":"Am J Transplant"},{"key":"R25-20250604","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1111\/ajt.13769","article-title":"Changes in discard rate after the introduction of the Kidney Donor Profile Index (KDPI).","volume":"16","author":"Bae","year":"2016","journal-title":"Am J Transplant"},{"key":"R26-20250604","doi-asserted-by":"crossref","first-page":"e13204","DOI":"10.1111\/tid.13204","article-title":"Trends in utilization of deceased donor kidneys based on hepatitis C virus status and impact of public health service labeling on discard.","volume":"22","author":"Ariyamuthu","year":"2020","journal-title":"Transpl Infect Dis"},{"key":"R27-20250604","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12910-022-00757-0","article-title":"Consent to organ offers from public health service \u201cincreased risk\u201d donors decreases time to transplant and waitlist mortality.","volume":"23","author":"Yvonne","year":"2022","journal-title":"BMC Med Ethics"},{"key":"R28-20250604","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1681\/ASN.2022040471","article-title":"Early effect of the circular model of kidney allocation in the United States.","volume":"34","author":"Puttarajappa","year":"2023","journal-title":"J Am Soc Nephrol"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000004929","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T18:04:09Z","timestamp":1749060249000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000004929"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,16]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000004929","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2,16]]}}}